Sarissa Capital Naminates Bernhard Ehmer to ARIAD Pharmaceuticals (ARIA) Board
Tweet Send to a Friend
In an amended 13D filing on ARIAD Pharmaceuticals (NASDAQ: ARIA), hedge fund Sarissa Capital Management LP disclosed a 6.88%, or ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
